Published in Health Business Week, October 2nd, 2009
"Dr. Chen brings valuable experience and expertise to the ongoing efforts at Regulus as we continue to lead the field in the discovery, development, and commercialization of microRNA therapeutics," said Kleanthis Xanthopoulos, Ph.D., President and Chief Executive Officer of Regulus. "We are delighted to have him join our team as we work towards...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Health Business Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.